System a neutral amino acid transporter regulation by interleukin-1β in human osteoarthritic synovial cells: Evidence for involvement of prostaglandin E2 as a second messenger

Journal of Cellular Physiology

Volumn 183, Issue 1, 2000, Pages 65-73

  Le Maire, Valérie ^a,b   Solito, Egle ^c   Russo Marie, Françoise ^c   Hernvann, Alain ^a,b   Le Marechal, Hervé ^a   Ekindjian, Ohvanesse G ^a,b   Aussel, Christian ^d  

^a Hôpital Cochin ^*  (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSTITUT COCHIN   (France)

^d Emile Roux Hospital AP HP   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 2 METHYLAMINOPROPIONIC ACID; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; PHOSPHOLIPASE A2; PROSTAGLANDIN E2;

AMINO ACID TRANSPORT; ARTICLE; ENZYME ACTIVATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SECOND MESSENGER; SYNOVIOCYTE;

AMINO ACID TRANSPORT SYSTEMS; ARACHIDONIC ACIDS; BETA-ALANINE; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOSOL; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INDANS; INTERLEUKIN-1; ISOENZYMES; KINETICS; MEMBRANE PROTEINS; OSTEOARTHRITIS; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SECOND MESSENGER SYSTEMS; SYNOVIAL MEMBRANE; XANTHENES; XANTHONES;

EID: 0034012610     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(200004)183:1<65::AID-JCP8>3.0.CO;2-H     Document Type: Article

References (44)

1. Angel J, Berenbaum F, Le Denmat C, Nevalainen T, Masliah J, Fournier C. 1994. Interleukin-1-induced prostaglandin E2 biosynthesis in human synovial cells involves the activation of cytosolic phospholipase A2 and cyclooxygenase-2. Eur J Biochem 226:125-131.
2. Aussel C, Rousseau-Loric S, Cynober L, Agneray J, Ekindjian OG. 1989. Neutral amino acid transport in human synovial cells: substrate specificity of adaptative regulation and transinhibition. J Cell Physiol 141:103-110.
3. Balsinde J, Barbour SE, Bianco ID, Dennis EA. 1994. Arachidonic acid mobilization in P388D1 macrophages is controlled by two distinct Ca(2+)-dependent phospholipase A2 enzymes. Proc Natl Acad Sci USA 91:11060-11064.
4. Balsinde J, Dennis EA. 1996. Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages. J Biol Chem 271:6758-6765.
5. Berenbaum F, Thomas G, Poiraudeau S, Béréziat G, Corvol MT, Masliah J. 1994. Insulin-like growth factors counteract the effect of interleukin-1β on type II phospholipase A2 expression and arachidonic release by rabbit articular chondrocytes. FEBS lett 340:51-55.
6. Biddulph DM, Capehart AA, Beasley TC. 1991. Comparative effects of cytosine arabinoside and a prostaglandin E2 antagonist, AH6809, on chondrogenesis in serum-free cultures of chick limb mesenchyme. Exp Cell Res 196:131-133.
7. Boerner P, Saier MH. 1985. Adaptative regulation control of system A transport activity in a kidney epithelial cell line (MDCK) and in a transformed variant (MDCK-T1). J Cell Physiol 122:308-315.
8. Bracy DS, Handlogten ME, Barber EF, Han HP, Kilberg MS. 1986. Cis-inhibition, transinhibition, and repression of hepatic amino acid transport mediated by system A. Substrate specificity and other properties. J Biol Chem 261:1514-1520.
9. Chan CC, Boyce S, Brideau C, Ford-Hutchinson AW, Gordon R, Guay D, Hill RG, Li CS, Mancini J, Penneton M, Prasit P, Rasori R, Riendeau D, Roy P, Tagari P, Vickers P, Wong E, Rodger IW. 1995. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745337: a novel anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther 274: 531-1537.
10. Clark JD, Schievella AR, Nalefski EA, Lin LL. 1995. Cytosolic phospholipase A2. J Lipid Med Cell Signal 12:83-117.
11. Croxtall JD, Newman SP, Choudhury Q, Flower RJ. 1996. The concerted regulation of cPLA2, COX-2 and lipocortin 1 expression by IL-1β in A549 cells. Biochem Biophys Res Commun 220:491-495.
12. Dennis EA. 1994. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem 269:13057-13060.
13. Gazzola GC, Dall'asta V, Guidotti GG. 1981. Adaptative regulation of amino acid transport in cultured human fibroblasts. Sites and mechanism of action. J Biol Chem 256:3191-3198.
14. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC, Seibert K. 1995. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J 305:479-484.
15. Gilman SC, Chang J, Zeigler PR, UhI J, Mochan E. 1988. Interleukin-1 activates phospholipase A2 in human synovial cells. Arthritis Rheum 31:126-130.
16. Goldring MB, Krane SM. 1987. Modulation by recombinant interleukin-1 of synthesis of type I and III collagens and associated procollagen mRNA levels in cultured human cells. J Biol Chem 262: 16724-16729.
17. Goldstein RH, Sakowski S, Meeker D, Franzblau C, Polgar P. 1986. The effect of prostaglandin E2 (PGE2) on amino acid uptake and protein formation by lung fibroblasts. J Biol Chem 261:8734-8738.
18. Guidotti GG, Gazzola GC. 1992. Amino acid transporters: systematic approach and principles of control. In: Kilberg MS, Häussinger D, editors. Mammalian amino acid transport. New York: Plenum Press. p 3-30.
19. Hulkower KI, Hope WC, Chen T, Anderson CM, Coffey JW, Morgan DW. 1992. Interleukin-1β stimulates cytosolic phospholipase A2 in rheumatoid synovial fibroblasts. Biochem Biophys Res Commun 184:712-718.
20. Kelley DS, Potter VR. 1978. Regulation of amino acid transport systems by amino acid depletion and supplementation in monolayer cultures of rat hepatocytes. J Biol Chem 253:9009-9017.
21. Kerr JS, Stevens TM, Davis GL, McLaughlin JA, Harris RR. 1989. Effects of recombinant interleukin-1 beta on phospholipase A2 activity, phospholipase mRNA levels, and eicosanoid formation in rabbit chondrocytes. Biochem Biophys Res Commun 165:1079-1084.
22. Knott I, Dieu M, Burton M, Houbion A, Remacle J, Raes M. 1994. Induction of cyclooxygenase by interleukin 1: comparative study between human synovial cells and chondrocytes. J Rheumatol 21: 462-466.
23. Kol S, Benshlomo I, Ando M, Payne DW, Adashi EY. 1997. Interleukin-1 beta stimulates ovarian phospholipase A2 expression and activity: up-regulation of both secretory and cytosolic PLA2. Endocrinology 138:314-321.
24. Le Maire V, Aussel C, Hernvann A, Launay JM, Ekindjian OG. 1994. Stimulation of α-(methylarmino)isobutyric acid uptake by interleukin-1 in human synovial cells. Involvement of a cAMP-dependent pathway. Eur Cytokine Netw 5:449-453.
25. Le Maire V, Hernvann A, Vaubourdolle M, Ekindjian OG, Aussel C. 1996. Dependence of adaptative regulation for IL-1β action on system A activity in human synovial cells. J Cell Physiol 168:721-726.
26. Lin LL, Lin AY, de Witt DL. 1992. Interleukin-1β induces the accumulation of cytosolic phospholipase A2 and the release of prostaglandin E2 in human fibroblasts. J Biol Chem 267:23451-23454.
27. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
28. Masferrer JL, Seibert K, Zweifel B, Needleman P. 1992. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 89:3917-3921.
29. Mochan E, Uhl J, Newton R. 1986. Evidence that interleukin-1 induction of synovial cell plasminogen activator is mediated via prostaglandin E2 and cAMP. Arthritis Rheum 29:1078-1084.
30. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
31. Murota SI, Kawamura M. 1977. Effects of prostaglandins on α-aminoisobutyric acid uptake in cultured fibroblasts. Biochem Biophys Res Commun 76:995-998.
32. Nakazato Y, Simonson MS, Herman WH, Konieczowski M, Sedor JR. 1991. Interleukin-1 stimulates prostaglandin biosynthesis in serum-activated mesangial cells by induction of a non-pancreatic-type II phospholipase A2. J Biol Chem 226:14119-14127.
33. Oka S, Arita H. 1996. Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J Biol Chem 266:9956-9960.
34. Orcel PH, Cohen-Solal M, de Vernejoul MC, Kuntz D. 1992. Déminéralisations osseuses et cytokines. Rev Rhum Mal Ostéoartic 59:16-22S.
35. Pfeilschifter J, Pignat W, Marki F, Wiesenberg I. 1989. Release of phospholipase A2 activity from vascular smooth muscle cells mediated by cAMP. Eur J Biochem 181:237-242.
36. Pfeilschifter J, Leighton J, Pignat W, Marki F, Vosbeck K. 1991. Cyclic AMP mimics, but does not mediate, interleukin-1 and tumour-necrosis-factor-stimulated phospholipase A2 secretion from rat mesangial cells. Biochem J 273:199-204.
37. Pfeilschifter J Schalkwijk C, Briner VA, van den Bosch H. 1993. Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest 92:2516-2523.
38. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. pp 73-80.
39. Seilhamer JJ, Pruzanski W, Vadas P, Plant S, Miller JA, Kloss J, Johnson LK. 1989. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J Biol Chem 264:5335-5338.
40. Schalkwijk CG, de Vet E, Pfeilschifter J, van den Bosch H. 1992. Interleukin-1 and transforming growth factor-2 enhance cytosolic high-molecular-mass phospholipase A2 activity and induce prostaglandin E2 formation in rat mesangial cells. Eur J Biochem 210: 169-176.
41. Shingu M, Hashimoto M, Ezaki I, Nobunaga M. 1994. Effect of cytokine-induced soluble ICAM-1 from human synovial cells on synovial cell-lymphocyte adhesion. Clin Exp Immunol 98:46-51.
42. Solito E, Raguenes-Nicol C, de Coupade C, Bisagni-Faure A, Russo-Marie F. 1998. U937 cells deprived of endogenous annexin 1 demonstrate an increased PLA2 activity. Br J Pharmacol 124:1675-1683.
43. Wery JP, Schevitz RW, Clawson DK, Bobbitt JL, Dow ER, Gamboa G, Goodson Jr T, Hermann RB, Kramer RM, McClure DB, Mihelich ED, Putnam JE, Sharp JD, Stark DH, Teater C, Warrick MW, Jones ND. 1991. Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution. Nature 352:79-82.
44. Woodward DF, Pepperl DJ, Burkey TH, Regan JW. 1995. 6-isopropoxy-9-oxoxanthene-2-carboxylic acid (AH6809), a human EP2 receptor antagonist. Biochem Pharmacol 50:1731-1733.